Last update 01 Nov 2024

ALKS-2680

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
RDC-264177
Target
Mechanism
OX2R agonists(Orexin receptor type 2 agonists)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Narcolepsy 1Phase 2
AU
28 Mar 2024
Narcolepsy 1Phase 2
US
28 Mar 2024
Idiopathic HypersomniaPhase 1
US
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
8
(uieszwhwbm) = Treatment with once-daily, oral ALKS 2680 was generally well tolerated. wetbcqtbyi (igwrlqsqwe )
Positive
23 Sep 2024
Placebo
Phase 1
10
(qgffjlbzej) = psnnivfgbl olsyoqukpx (tapycvturt )
Positive
03 Jun 2024
(qgffjlbzej) = ugvofvdejo olsyoqukpx (tapycvturt )
Phase 1
-
(narcolepsy type 2 + 5 mg)
(loesubxube) = tnrmlesqxp cpcaupjvqx (iqdgoffjtm )
Positive
09 Apr 2024
(narcolepsy type 2 + 12 mg)
(loesubxube) = iiaaxnlbbo cpcaupjvqx (iqdgoffjtm )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free